Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
标准辅助化疗剂量是否会影响三阴性乳腺癌患者从延长卡培他滨节拍化疗中获益？SYSUCC-001试验的探索性分析
期刊:Breast Cancer-Targets and Therapy
影响因子:3.4
doi:10.2147/BCTT.S447290
Chen, Ying; Li, Wen-Xia; Wu, Jia-Hua; Chen, Geng-Hang; Yang, Chun-Min; Lu, Hai; Wang, Xi; Wang, Shu-Sen; Huang, Heng; Cai, Li; Zhao, Li; Peng, Rou-Jun; Lin, Ying; Tang, Jun; Zeng, Jian; Zhang, Le-Hong; Ke, Yong-Li; Wang, Xian-Ming; Liu, Xin-Mei; Zhang, An-Qin; Xu, Fei; Bi, Xi-Wen; Huang, Jia-Jia; Li, Ji-Bin; Pang, Dan-Mei; Xue, Cong; Shi, Yan-Xia; He, Zhen-Yu; Lin, Huan-Xin; An, Xin; Xia, Wen; Cao, Ye; Guo, Ying; Hong, Ruo-Xi; Jiang, Kui-Kui; Zhong, Yong-Yi; Zhang, Ge; Tienchaiananda, Piyawan; Oikawa, Masahiro; Yuan, Zhong-Yu; Chen, Qian-Jun
